Gout & crystal arthritis

Relation of Colchicine to Total Joint Arthroplasty Among People With Gout in a Population‐Based Cohort Study

Arthritis RheumatolPublished Population-based cohort study

Main finding · TJAResult — go to the resultHazard ratio 0.88 95% CI 0.81–0.96

Authors' conclusion

In this large population-based cohort of people with gout, colchicine initiation was associated with a modestly lower risk of TJA.

Study context

Population
Participants with gout, UK primary care database (2000–2021); mean age 60 years, mean BMI 30median follow-up 4.5 years
Exposure
Colchicine initiators vs propensity score matched noninitiators
  • Colchicine initiatorsn = 31,478
Outcome
Risk of total joint arthroplasty (TJA)
Methodological detailsnew-user design, time-stratified, propensity score matched, Cox proportional hazard regression
  • New-user design
  • Time-stratified
  • Propensity score matched
  • Cox proportional hazard regression

Main finding

TJA

Hazard ratio

0.88

95% CI 0.81–0.96

Colchicine initiatorsvs Noninitiators
HR 0.88 (95% CI 0.81–0.96)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
TJA in participants with gout and knee/hip OA (subgroup)0.77 (0.64–0.92)

Total joint arthroplasty (TJA) in participants with gout and knee/hip osteoarthritis (OA) (subgroup)

23% lower risk of TJA

Original publication

Relation of Colchicine to Total Joint Arthroplasty Among People With Gout in a Population‐Based Cohort Study. Arthritis Rheumatol. Published 6 February 2026. doi:10.1002/art.43441

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.